Futura Medical PLC (LON:FUM) said CSD500, its erectogenic condom, is now on sale in Saudi Arabia under the brand name Futura Max Manex Super.
The condoms, designed to help men maintain an erection and maximise penile size, are now on sale in Saudi Arabia under the brand name Futura Max Manex Super.
The launch of the product has been overseen by Kabey Pharmaceuticals, the company’s distribution partner for key territories in the Middle East and North Africa (MEA).
Kabey expects to launch the product in other territories within MENA this year.
The launch follows positive feedback from urologists after their trial use of the product.
In addition to raising further medical awareness of the product with urologists, Kabey will now implement a direct retail marketing campaign.
"Kabey is well-established with a strong presence in the MENA region. It will now implement a direct retail marketing campaign which we are confident will be successful for CSD500. We look forward to updating the market regarding further launches of CSD500 within MENA during 2017," said James Barder, chief executive of Futura.
Shares in Futura practically doubled last year, with the share price rise really kicking in from September, when the company said shelf-life issues with the CSD500 condoms had been resolved.